NCT02309892 - A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 20, 2015

Primary Completion Date

August 19, 2019

Study Completion Date

September 20, 2019

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

L-DOS47

A treatment cycle will be 21 days, with patients receiving L-DOS47 on cycle Days 1, 8, and 15 and pemetrexed/carboplatin on Day 1 of each treatment cycle.

Trial Locations (2)

Unknown

University Hospitals Case Medical Center, Cleveland

The University of Texas MD Anderson Cancer Center, Houston